Data / Form D filings / Zymeworks Inc.
Zymeworks Inc.: Form D filings
Zymeworks Inc., a biotechnology company in Vancouver, British Columbia, Canada, filed 11 Form D notices with the SEC between 2009 and 2016. The latest, on January 21, 2016, reports $61.5 million sold of a $75 million offering to 15 investors.
Find out what Zymeworks Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 540-1385 WEST 8TH AVENUE, Vancouver, British Columbia, Canada, V6H 3
- Phone
- (604) 678-1388
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1403752
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 21, 2016 | New notice | $75,000,003 | $61,517,859 | $13,482,144 | 15 | Jan 7, 2016 | sec.gov |
| Feb 27, 2015 | New notice | $1,785,700 | $1,785,700 | $0 | 1 | Feb 17, 2015 | sec.gov |
| Jan 20, 2015 | Amendment | $23,988,700 | $23,988,700 | $0 | 1 | Oct 22, 2014 | sec.gov |
| Jan 8, 2015 | New notice | $8,601,260 | $8,601,260 | $0 | 1 | Dec 24, 2014 | sec.gov |
| Nov 4, 2014 | New notice | $27,000,000 | $27,000,000 | $0 | 1 | Oct 22, 2014 | sec.gov |
| Apr 21, 2014 | Amendment | $1,025,752 | $1,025,752 | $0 | 3 | Dec 6, 2013 | sec.gov |
| Feb 14, 2014 | Amendment | $949,288 | $949,288 | $0 | 2 | Dec 6, 2013 | sec.gov |
| Dec 17, 2013 | New notice | $20,000 | $20,000 | $0 | 1 | Dec 6, 2013 | sec.gov |
| Aug 22, 2012 | New notice | $10,853,700 | $10,853,700 | $0 | 31 | Aug 16, 2012 | sec.gov |
| Oct 27, 2011 | New notice | $7,092,463 | $7,092,463 | $0 | 25 | Jun 19, 2009 | sec.gov |
| Jul 2, 2009 | New notice | $451,847 | $451,847 | $0 | 9 | Jun 19, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| SHERMAINE TILLEY | Director | |
| DION MADSEN | Director | |
| DONALD DRAKEMAN | Director | |
| KENNETH GALBRAITH | Director | |
| GORDON NG | Executive Officer | |
| DAVID TUCKER | Executive Officer | |
| NEIL KLOMPAS | Executive Officer | |
| NOEL HALL | Director | |
| ALI TEHRANI | Executive Officer, Director | |
| SURJIT DIXIT | Executive Officer | |
| AMOS MICHELSON | Director | |
| NICK BEDFORD | Director |
Every Form D from the week of Jan 18, 2016 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Zymeworks Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.